Therefore, it is hypothesized that decreased DKK3 levels in patients after ischemic stroke may be a risk factor for poor prognosis, and therefore detection of DKK3 levels at admission can predict the adverse outcomes in patients. This evidence concerns the gene DKK3 and ischemic stroke.